Published online 6 August 2004
Nucleic Acids Research, Vol. 32 No. 14 © Oxford University Press 2004; all rights reserved
Essential structural and functional determinants within the forkhead domain of FOXC1
1 Department of Medical Genetics and 2 Department of Ophthalmology, 832 Medical Sciences Building, University of Alberta, Edmonton, Alberta, Canada T6G 2H7, USA and 3 Genome Technology Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA
* To whom correspondence should be addressed. Tel: +1 780 492 9805; Fax: +1 780 492 6934; Email: mwalter{at}ualberta.ca
Present address: R. A. Saleem, The Institute for Systems Biology, Seattle, WA, USA
Received as resubmission June 9, 2004; Revised and Accepted July 15, 2004
The forkhead domain (FHD)-containing developmental transcription factor FOXC1 is mutated in patients presenting with AxenfeldRieger malformations. In this paper, we report the introduction of positive, negative or neutral charged amino acids into critical positions within the forkhead domain of FOXC1 in an effort to better understand the essential structural and functional determinants within the FHD. We found that FOXC1 is intolerant of mutations at I87. Additionally, alterations of amino acids within
-helix 1 of the FOXC1 FHD affected both nuclear localization and transactivation. Amino acids within
-helix 3 were also found to be necessary for transactivation and can have roles in correct localization. Interestingly, changing amino acids within
-helix 3, particularly R127, resulted in altered DNA-binding specificity and granted FOXC1 the ability to bind to a novel DNA sequence. Given the limited topological variation of FHDs, due to the high conservation of residues, we anticipate that models of forkhead domain function derived from these data will be relevant to other members of the FOX family of transcription factors.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
J. Ouellet, S. Li, and R. Roy Notch signalling is required for both dauer maintenance and recovery in C. elegans Development, August 1, 2008; 135(15): 2583 - 2592. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Beysen, L. Moumne, R. Veitia, H. Peters, B. P. Leroy, A. De Paepe, and E. De Baere Missense mutations in the forkhead domain of FOXL2 lead to subcellular mislocalization, protein aggregation and impaired transactivation Hum. Mol. Genet., July 1, 2008; 17(13): 2030 - 2038. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. A. Ito, T. K. Footz, T. C. Murphy, W. Courtens, and M. A. Walter Analyses of a Novel L130F Missense Mutation in FOXC1 Arch Ophthalmol, January 1, 2007; 125(1): 128 - 135. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Weisschuh, P. Dressler, F. Schuettauf, C. Wolf, B. Wissinger, and E. Gramer Novel Mutations of FOXC1 and PITX2 in Patients with Axenfeld-Rieger Malformations. Invest. Ophthalmol. Vis. Sci., September 1, 2006; 47(9): 3846 - 3852. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. B. Berry, Y. Tamimi, M. V. Carle, O. J. Lehmann, and M. A. Walter The establishment of a predictive mutational model of the forkhead domain through the analyses of FOXC2 missense mutations identified in patients with hereditary lymphedema with distichiasis Hum. Mol. Genet., September 15, 2005; 14(18): 2619 - 2627. [Abstract] [Full Text] [PDF] |
||||



